Head-to-head · Cost-Efficiency Index
CeliaRx vs MediRX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CeliaRx
Cost-first shoppers who want peptide-experienced buyers wanting a la carte purchases rather than a structured monthly weight-loss program.
Visit CeliaRxMediRX
Shoppers who want transparent published pricing and don't mind that prescribing is handled by a third-party clinician network (OpenLoop) rather than an in-house medical team.
Visit MediRXThe verdict
CeliaRx and MediRX tie on the Cost-Efficiency Index at 55/100, so neither wins outright on the numbers. For most shoppers we'd start with CeliaRx (ranked #337, a hair above #339) — Cost-first shoppers who want peptide-experienced buyers wanting a la carte purchases rather than a structured monthly weight-loss program. But MediRX is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs CeliaRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CeliaRx | MediRX |
|---|---|---|
| Cost-Efficiency Index | 55/100 | 55/100 |
| Semaglutide / mo | $299/mo (2 mg dose, compounded oral) | $149/mo (starting dose, compounded) |
| Tirzepatide / mo | $699/mo (34 mg dose, compounded) | $199/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $3,588 | $1,788 |
| Tirzepatide / yr (modeled) | $8,388 | $2,388 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #337 | #339 |
CeliaRx
55/100Where the value is
- LegitScript seal displayed
- Offers both injectable and oral-dissolving-tablet formats
- Multiple dose tiers available for both drugs
The tradeoffs
- Not primarily positioned as a weight-loss clinic -- broader peptide/longevity focus dilutes clinical weight-loss framing
- No disclosed supply duration per SKU, so real monthly cost can't be confirmed from the site
MediRX
55/100Where the value is
- Publishes specific dollar pricing for both injection and oral-tablet forms of both drugs
- Rare self-disclosed distinction between promotional ($149) and standard ($179) semaglutide pricing
- LegitScript badge displayed on the page
The tradeoffs
- MediRx itself has no named medical director -- all clinical care is outsourced to OpenLoop Health's network
- Tirzepatide's wide $199-$399 range makes the true likely monthly cost at a therapeutic dose unclear
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.